The Evaluation of the Therapeutic Potential and Risks of the Ketogenic Diet
DOI:
https://doi.org/10.54097/1ds94c21Keywords:
Ketogenic diet; obesity; metabolic health.Abstract
As the demand for weight loss increases, the ketogenic diet (KD) has gradually attracted public attention and become one of the most popular dietary choices. This diet is characterized by high fat and low carbohydrates and was originally used to treat epilepsy. In recent years, studies have shown that KD has potential benefits in controlling obesity, improving metabolic syndrome, reducing insulin requirements in patients with type 2 diabetes, and alleviating inflammation. However, the effectiveness, safety, and risks of KD during pregnancy still need to be further verified. This article aims to explore the benefits and risks of KD as a dietary treatment and to clarify the differences between ketogenic diets for epilepsy and obesity. Studies have shown that KD improves multiple health indicators by inducing ketone body production and has therapeutic potential in certain neurodegenerative diseases. However, KD is also accompanied by certain side effects, such as hypoglycemia, digestive problems, and malnutrition, especially in children and elderly patients. Although KD performs well in controlling weight and improving blood sugar levels, its effects on cardiovascular disease, microbiome regulation, and cancer control need to be further studied. This article reveals the potential therapeutic value of KD for multiple diseases through a comprehensive evaluation of existing research results and emphasizes the importance of future research on dietary recommendations to promote health improvement.
Downloads
References
[1] McGaugh E, Barthel B. A Review of Ketogenic Diet and Lifestyle[J]. Missouri Medicine, 2022, 119(1): 84-88.
[2] Dowis K, Banga S. The Potential Health Benefits of the Ketogenic Diet: A Narrative Review[J]. Nutrients, 2021, 13(5): 1654.
[3] Shahpasand S, Khatami S H, Ehtiati S, et al. Therapeutic potential of the ketogenic diet: A metabolic switch with implications for neurological disorders, the gut-brain axis, and cardiovascular diseases[J]. The Journal of Nutritional Biochemistry, 2024: 109693.
[4] Zhou C, Wang M, Liang J, et al. Ketogenic Diet Benefits to Weight Loss, Glycemic Control, and Lipid Profiles in Overweight Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials[J]. International Journal of Environmental Research and Public Health, 2022, 19(16): 10429.
[5] Santangelo A, Corsello A, Spolidoro G C I, et al. The Influence of Ketogenic Diet on Gut Microbiota: Potential Benefits, Risks and Indications[J]. Nutrients, 2023, 15(17): 3680.
[6] Paoli A, Mancin L, Bianco A, et al. Ketogenic Diet and Microbiota: Friends or Enemies?[J]. Genes, 2019, 10(7): 534.
[7] Corsello A, Trovato C M, Profio E D, et al. Ketogenic diet in children and adolescents: The effects on growth and nutritional status[J]. Pharmacological Research, 2023: 106780.
[8] Popiolek-Kalisz J. Ketogenic diet and cardiovascular risk – state of the art review[J]. Current Problems in Cardiology, 2024: 102402.
[9] Ułamek-Kozioł M, Czuczwar S J, Januszewski S, et al. Ketogenic Diet and Epilepsy[J]. Nutrients, 2019, 11(10): 2510.
[10] Löscher W, Potschka H, Sisodiya S M, et al. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options[J]. Pharmacological Reviews, 2020, 72(3): 606-638.
[11] Santangelo A, Corsello A, Spolidoro G C I, et al. The Influence of Ketogenic Diet on Gut Microbiota: Potential Benefits, Risks and Indications[J]. Nutrients, 2023, 15(17): 3680.
[12] Schoeler N E, Ridout D, Neal E G, et al. Maintenance of response to ketogenic diet therapy for drug-resistant epilepsy post diet discontinuation: A multi-centre case note review[J]. Seizure: European Journal of Epilepsy.
[13] Paoli A. Ketogenic diet for obesity: friend or foe?[J]. International Journal of Environmental Research and Public Health, 2014, 11(2): 2092-2107.
[14] Zhou C, Wang M, Liang J, et al. Ketogenic Diet Benefits to Weight Loss, Glycemic Control, and Lipid Profiles in Overweight Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials[J]. International Journal of Environmental Research and Public Health, 2022, 19(16): 10429.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







